Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Links between poor animal welfare and the spread of antimicrobial resistance (AMR) have been highlighted by a US campaign group.
The University of Aarhus in Denmark claims there are "unanswered questions" regarding the use of local anesthesia when castrating piglets.
Bayer Animal Health has entered a collaboration with R&D service provider Pharmaron to develop new molecular entities.
The US FDA has issued warning letters to 15 companies for illegally selling products containing cannabidiol (CBD).
The US FDA has given a makeover to the National Antimicrobial Resistance Monitoring System (NARMS).
Kindred Biosciences' Zimeta (dipyrone injection) has become the first US FDA-approved product for the control of pyrexia in horses.
The US FDA has issued new draft guidance regarding the compounding of certain animal drugs.
Spain's Labiana Life Sciences has acquired vaccines and chemotherapy specialist Veterinarski Zavod Subotica.
Subscribers have five weeks to nominate their company and innovations as part of the Animal Pharm Awards for 2019.
European authorities have given the go-ahead for Boehringer Ingelheim Animal Health's Aservo EquiHaler to be approved.
US firm Zomedica Pharmaceuticals has seen its net loss for the year-to-date already surpass its annual loss during the whole of 2018.
Over the past five years, the Bill & Melinda Gates Foundation has established partnerships to improve access to quality veterinary healthcare in sub-Saharan Africa. However, it believes there is still the potential to do much more. Animal Pharm's head of reports Dr Alan Bullion attended an animal health meeting organized by the Gates Foundation in London to find out more, while editor Joseph Harvey spoke to one of the organization's leaders in the livestock sector.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.